Leprosy
📧 Sign up to get email alerts when something new happens for Leprosy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients [Phase 1, Phase 2]
Phase 1b/2a trial evaluating LEP-F1 + GLA-SE in healthy adults and leprosy patients; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Treatment of Neuropathic Pain in Leprosy [Phase 3]
Phase 3 trial update for treatment of neuropathic pain in leprosy.
-
FDA approval · 2022-02-10FDA Approved: DAPSONE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved the original application for DAPSONE (dapsone) as a generic drug manufactured by Torrent Pharmaceuticals Limited.
-
FDA approval · 2022-02-04FDA Approved: DAPSONE — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved an original application for DAPSONE from Mylan Pharmaceuticals, granting generic market authorization.
-
FDA approval · 2021-09-14FDA Approved: RIFAMPIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Rifampin under the ANDA. The approval indicates changes to the Rifampin pro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: CC-11050 Trial in Nepalese Patients With Erythema Nodosum Leprosum [Phase 2]
Clinical trial update for CC-11050 in Nepalese patients with Erythema Nodosum Leprosum (ENL) in Phase 2.
-
FDA approval · 2019-05-08FDA Approved: DAPSONE — Original Application (Rising Pharma Holdings, Inc.)
FDA approves the Original Application for DAPSONE from Rising Pharma Holdings, Inc., enabling a generic version of the drug.
-
FDA approval · 2017-10-16FDA Approved: DAPSONE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic version of dapsone (DAPSONE) through an original ANDA. The approval authorizes the sale …
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Uniform Multidrug Therapy Regimen for Leprosy Patients [Phase 4]
Phase 4 clinical trial evaluating a uniform multidrug therapy regimen for leprosy; the study has completed.
-
CLINICAL_TRIALS research · 2017-03-07Clinical Trial Update: Low Level Laser Therapy Effects in Peripheral Nerves Patient With Leprosy. [NA]
This entry reports a clinical trial investigating low level laser therapy for peripheral nerve involvement in leprosy neuropathy, with the t…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome [Phase 4]
Phase 4 study assessing whether genetic screening for HLA-B*1301 can predict susceptibility to dapsone hypersensitivity syndrome.
-
FDA approval · 2016-12-01FDA Approved: DAPSONE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' generic DAPSONE (dapsone) under an Original Application (ANDA206505).
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Effect of Weight and/or Obesity on Dapsone Drug Concentrations [Phase 4]
A Phase 4 clinical trial evaluated whether weight and obesity influence dapsone drug concentrations, involving participants with obesity and…
-
FDA approval · 2016-05-10FDA Approved: DAPSONE — Original Application (Chartwell RX, LLC)
The FDA approved the original ANDA for DAPSONE from Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Impact of the Virtual Human Project on Team-based Learning: A Randomized-controlled Trial [NA]
A completed randomized-controlled trial evaluating the impact of the Virtual Human Project on team-based learning in the context of leprosy.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Effect of Additional Clofazimine on Erythema Nodosum Leprosum (ENL) Reactions in Leprosy [Phase 4]
Phase 4 trial assessing whether adding extra clofazimine reduces erythema nodosum leprosum reactions in leprosy patients; study status is co…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy
Clinical trial update describing a long-term treatment protocol using clofazimine for leprosy; the study is no longer available.
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum [Phase 2]
A Phase 2 clinical trial evaluating ciclosporin for the management of chronic or recurrent erythema nodosum leprosum in leprosy has complete…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in Leprosy [Phase 2]
Phase 2 clinical trial update on using ciclosporin to manage steroid-resistant Type 1 reactions in leprosy, with the study status listed as …
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Ciclosporin in the Management of New Erythema Nodosum Leprosum [Phase 2]
A Phase 2 clinical trial evaluating ciclosporin for the management of new erythema nodosum leprosum in patients with leprosy; the study stat…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Ciclosporin in the Management of New Type 1 Reactions in Leprosy [Phase 2, Phase 3]
A Phase 2/Phase 3 study evaluating cyclosporine for the management of Type 1 reactions in leprosy has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: Molecular and Immunological Tools for Detection of Strain Diversity, Drug Resistance and Immunological Responses
This completed clinical trial from Colorado State University evaluated molecular and immunological tools for detecting strain diversity, dru…
-
FDA approval · 2014-08-21FDA Approved: RIFAMPIN — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's generic rifampin (RIFAMPIN) under an Original Application (ANDA), expanding access to this antibiotic…
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: Leprosy Skin Test Antigens Phase 1 [Phase 1]
Phase 1 clinical trial update on leprosy skin-test antigens; the study has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: Microcirculatory Impairment in Patients With Leprosy [NA]
This update reports on a completed clinical trial evaluating microcirculatory impairment in patients with leprosy.